Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States

Natalie C. Weber, Michael E. Klepser, Julie M. Akers, Donald G. Klepser, Alex J. Adams

Research output: Contribution to journalArticlepeer-review

25 Scopus citations


Review of point-of-care (POC) testing in community pharmacies, availability and specifications of CLIA-waived infectious disease POC tests, and provide recommendations for future community pharmacy POC models in an effort to improve patient outcomes while reducing antibiotic resistance. PubMed and Medscape were searched for the following keywords: infectious disease, community pharmacy, rapid diagnostic tests, rapid assay, and POC tests. All studies utilizing POC tests in community pharmacies for infectious disease were included. Studies, articles, recommendations, and posters were reviewed and information categorized into general implementation of POC testing in community pharmacies, CLIA-waived tests available, Influenza, Group A Streptococcus pharyngitis, Helicobacter pylori, HIV and Hepatitis C. POC testing provides a unique opportunity for community pharmacists to implement collaborative disease management programmes for infectious diseases and reduce over-prescribing of antibiotics and improve patient outcomes through early detection, treatment and/or referral to a specialist.

Original languageEnglish (US)
Pages (from-to)253-264
Number of pages12
JournalExpert Review of Molecular Diagnostics
Issue number2
StatePublished - Feb 1 2016


  • CLIA-waived tests
  • HIV
  • Hepatitis C
  • Point-of-care test
  • infectious diseases
  • influenza
  • pharmacy
  • streptococcal pharyngitis

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Molecular Medicine
  • Molecular Biology
  • Genetics


Dive into the research topics of 'Use of CLIA-waived point-of-care tests for infectious diseases in community pharmacies in the United States'. Together they form a unique fingerprint.

Cite this